XTANT MEDICAL HOLDINGS, INC. (XTNT) Free cash flow 2016–2025
XTANT MEDICAL HOLDINGS, INC. (XTNT) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
$10.2MFY2025 · since FY2016: -$20.2M → $10.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $10.2M | +163.5% |
| FY2024 | -$16.0M | -45.9% |
| FY2023 | -$11.0M | -54.4% |
| FY2022 | -$7.1M | -323.9% |
| FY2021 | -$1.7M | +26.4% |
| FY2020 | -$2.3M | -76.2% |
| FY2019 | -$1.3M | -319.7% |
| FY2018 | $588,000 | +126.9% |
| FY2017 | -$2.2M | +89.2% |
| FY2016 | -$20.2M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More XTNT financial trends
XTNT RevenueXTNT Net incomeXTNT Net marginXTNT Gross profitXTNT Gross marginXTNT Operating incomeXTNT Operating marginXTNT Operating cash flowXTNT Capital expendituresXTNT Return on equityXTNT Stock buybacksXTNT Dividends paidXTNT Total assetsXTNT Total liabilitiesXTNT Shareholders’ equityXTNT overview →